Study of hard-to-treat Crohn's disease
Part of Digestive system clinical trials.
This study looks at people with Crohn's disease that is hard to treat. It aims to understand the disease better and see how well current treatments work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Crohn's disease.
- You are between 18 and 65 years old.
- You agree to take part and sign a consent form.
- You are not currently in another clinical trial or taking experimental drugs.
- You do not have a condition that makes biologics or similar drugs unsafe (like an active infection or pregnancy).
- You do not have short bowel syndrome or a stoma (surgical opening in the belly for waste).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at proteins from your body and gut bacteria to understand Crohn's disease better. You may join if you are about to have your first colonoscopy for suspected Crohn's and have not had any treatment yet.
This study follows children newly diagnosed with Crohn’s disease to see how results from scans and endoscopy (camera scope) relate to outcomes over the first year. It may help doctors choose better early treatment plans and monitor children more effectively.
This study looks at how bacteria in the gut may affect scarring (fibrosis) in the intestines, especially in people with Crohn's disease. By joining, you may help researchers understand why scarring happens, which could lead to better treatments.
This early-phase study tests whether a stem cell transplant can improve Crohn’s disease in teens and young adults whose disease is active and not responding to standard medicines. It may help some people who are not doing well despite several prior treatments, but it also involves intensive study procedures and safety checks.
This study tests whether a special diet using a nutritional supplement can reduce inflammation and improve symptoms in people with active Crohn's disease affecting the small intestine. It aims to see how the diet changes gut bacteria and body composition.
This study looks at blood and/or tissue “molecular” (cell-level) reasons why treatments don’t fully work in adults with Crohn’s disease or ulcerative colitis. If you are starting a biologic or small-molecule medicine and still have moderate to severe symptoms, you may be able to contribute to research that helps improve future care.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.